SPOTLIGHT -
Depression predominates across the lifespan in patients with bipolar disorder. Here: A discussion about (and beyond) the four FDA-approved drugs to treat symptoms.
Late-Life Treatment-Resistant Depression
Blue Light Blockers: A Behavior Therapy for Mania
Tackling Treatment-Resistant Depression
Blue Light, Depression, and Bipolar Disorder
The First and Only 5HT1a Receptor Agonist for Major Depressive Disorder
Head-to-Head Comparison of Vortioxetine Versus Desvenalfaxine in Patients With Depression and Partial Response to SSRIs